Lithium and genetic inhibition of GSK3β enhance the effect of methamphetamine on circadian rhythms in the mouse

Behavioural Pharmacology

Volumn 20, Issue 2, 2009, Pages 174-183

  Mohawk, Jennifer A ^a   Miranda Anaya, Manuel ^b   Tataroglu, Ozgur ^c   Menaker, Michael ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Circadian rhythms; Glycogen synthase kinase 3b; Lithium; Methamphetamine; Mouse

Indexed keywords

DNA; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; METHAMPHETAMINE; SODIUM CHLORIDE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; FEMALE; GENOTYPE; HETEROZYGOTE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; STEREOTYPY; TRANSGENIC MOUSE; WHEEL RUNNING BEHAVIOR; ALLELE; ANIMAL; BLOOD; C57BL MOUSE; GENETICS; METABOLISM; MOTOR ACTIVITY; MOUSE MUTANT; PHOTOPERIODICITY;

ALLELES; ANIMALS; CIRCADIAN RHYTHM; DRUG SYNERGISM; GLYCOGEN SYNTHASE KINASE 3; HETEROZYGOTE; LITHIUM; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MOTOR ACTIVITY; PHOTOPERIOD;

EID: 66549083857     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32832a8f43     Document Type: Article

References (51)

1. Abe M. Herzog ED, Block GD (2000). Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons. Neuroreport 11:3261-3264.
2. Aschoff J (1960). Exogenous and endogenous components in circadian rhythms. Cold Spring Harb Symp Quant Biol 25:11-28.
3. Bauer M, Adli M, Baethge C, Berghofer A, Sasse J, Heinz A, et al. (2003). Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms. Can J Psychiatry 48:440-448.
4. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG (2004). Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acadsci U S A 101:5099-5104.
5. Bizzarri JV, Sbrana A, Rucci P, Ravani L, Massei GJ, Gonnelli C, et al. (2007). The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity. Bipolar Disord 9:213-220.
6. Boivin DB, Duffy JF, Kronauer RE, Czeisler CA (1996). Dose-response relationships for resetting of human circadian clock by light. Nature 379:540-542.
7. Cassidy F, Ahearn EP, Carroll BJ (2001). Substance abuse in bipolar disorder. Bipolar Disord 3:181-188.
8. Daan S, Pittendrigh CS (1976). Functional-analysis of circadian pacemakers in nocturnal rodents. 3. heavy-water and constant light-homeostasis of frequency. J Comp Physiol 106:267-290.
9. De Groot MH, Rusak B (2004). Housing conditions influence the expression of food-anticipatory activity in mice. Physiol Behav 83:447-457.
10. De Sarno P, Li X, Jope RS (2002). Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43:1158-1164.
11. Dokucu ME, Yu L, Taghert PH (2005). Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila. Neuropsychopharmacology 30:2216-2224.
12. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, et al. (2005). The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 162:656-662.
13. Gould TD, Manjl HK (2005). Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30:1223-1237.
14. Gould TD, Quiroz JA, Singh J, Zarate CA, Manjl HK (2004). Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol Psychiatry 9:734-755.
15. Hafen T, Wollnik F (1994). Effect of lithium carbonate on activity level and circadian period in different strains of rats. Pharmacol Biochem Behav 49:975-983.
16. Honma K, Honma S, Hiroshige T (1986). Disorganization of the rat activity rhythm by chronic treatment with methamphetamine. Physiol Behav 38:687-695.
17. Honma K, Honma S, Hiroshige T (1987). Activity rhythms in the circadian domain appear in suprachiasmatic nuclei lesioned rats given methamphetamine. Physiol Behav 40:767-774.
18. Iitaka C, Miyazaki K, Akaike T, Ishida N (2005). A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem 280:29397-29402.
19. Iwahana E, Akiyama M, Miyakawa K, Uchida A, Kasahara J, Fukunaga K, et al. (2004). Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei. Eur J Neurosci 19:2281-2287.
20. Jensen J, Thomsen K, Olesen OV (1976). Current determination of lithium-induced minimum sodium requirement in rats. Psychopharmacologia 45:295-299.
21. Johnsson A, Engelmann W, Pflug B, Klemke W (1983). Period lengthening of human circadian rhythms by lithium carbonate, a prophylactic for depressive disorders. Int J Chronobiol 8:129-147.
22. Kaladchibachi SA, Doble B, Anthopoulos N, Woodgett JR, Manoukian AS (2007). Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. J Circadian Rhythms 5:3.
23. Katz G, Durst R, Zislin Y., Barel Y., Knobler HY (2001). Psychiatric aspects of jet lag: review and hypothesis. Med Hypotheses 56:20-23.
24. Klemfuss H (1992). Rhythms and the pharmacology of lithium. Pharmacol Ther 56:53-78.
25. Lee Y, Hamamura T., Ohashi K, Fujiwara Y, Kuroda S (1999). The effect of lithium on methamphetamine-induced regional Fos protein expression in the rat brain. Neuroreport 10:895-900.
26. LeSauter J, Silver R (1993). Lithium lengthens the period of circadian rhythms in lesioned hamsters bearing SCN grafts. Biol Psychiatry 34:75-83.
27. Li X, Bijur GN, Jope RS (2002). Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disord 4:137-144.
28. Masubuchi S, Honma S, Abe H, Nakamura W, Honma K (2001). Circadian activity rhythm in methamphetamine-treated Clock mutant mice. Eur J Neurosci 14:1177-1180.
29. Miyauchi T, Kikuchi K, Satoh S (1981). Further studies on the potentiating effect of lithium chloride on methamphetamine-induced stereotypy in mice. Jpn J Pharmacol 31:61-68.
30. Mrosovsky N (1999). Further experiments on the relationship between the period of circadian rhythms and locomotor activity levels in hamsters. Physiol Behav 66:797-801.
31. Munoz M, Peirson SN. Hankins MW, Foster RG (2005). Long-term constant light induces constitutive elevated expression of mPER2 protein in the murine SCN: a molecular basis for Aschoff's rule? J Biol Rhythms 20:3-14.
32. Namima M, Sugihara K, Watanabe Y, Sasa H, Umekage T, Okamoto K (1999). Quantitative analysis of the effects of lithium on the reverse tolerance and the c-Fos expression induced by methamphetamine in mice. Brain Res Brain Res Protoc 4:11-18.
33. O'Brien WT, Harper AD, Jove F, Woodgett JR, Maretto S, Piccolo S, Klein PS (2004). Glycogen synthase kinase-3beta haploinsufflciency mimics the behavioral and molecular effects of lithium. J Neurosci 24:6791-6798.
34. O'Donnell KC, Gould TD (2007). The behavioral actions of lithium in rodent models: leads to develop novel therapeutics. Neurosci Biobehav Rev 31:932-962.
35. Ozawa H, Miyauchi T (1977). Potentiating effect of lithium chloride on methamphetamine-induced stereotypy in mice. Eur J Pharmacol 41:213-216.
36. Padiath QS, Paranjpe D, Jain S, Sharma VK (2004). Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks. Chronobiol Int 21:43-65.
37. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, et al. (2007). Mania-like behavior induced by disruption of CLOCK. Proc Natl Acadsci U S A 104:6406-6411.
38. Ruis JF, Rietveld WJ, Buys JP (1991). Properties of parametric photic entrainment of circadian rhythms in the rat. Physiol Behav 50:1233-1239.
39. Ryves WJ, Harwood AJ (2001). Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280:720-725.
40. Slawson MH, Taccogno JL, Foltz RL, Moody DE (2002). Quantitative analysis of selegiline and three metabolites (N-desmethylselegiline, methamphetamine, and amphetamine) in human plasma by high-performance liquid chromato-graphy- atmospheric pressure chemical ionization-tandem mass spectrometry. J Anal Toxicol 26:430-437.
41. Sudo M, Sasahara K, Moriya T, Akiyama M, Hamada T, Shibata S (2003). Constant light housing attenuates circadian rhythms of mPer2 mRNA and mPER2 protein expression in the suprachiasmatic nucleus of mice. Neuroscience 121:493-499.
42. Takahashi JS, DeCoursey PJ, Bauman L, Menaker M (1984). Spectral sensitivity of a novel photoreceptive system mediating entrainment of mammalian circadian rhythms. Nature 308:186-188.
43. Tataroglu O, Davidson AJ, Benvenuto LJ, Menaker M (2006). The metham-phetamine-sensitive circadian oscillator (MASCO) in mice. J Biol Rhythms 21:185-194.
44. Wehr TA, Wirz-Justice A (1982). Circadian rhythm mechanisms in affective illness and In antidepressant drug action. Pharmacopsychiatria 15:31-39.
45. Welsh DK, Moore-Ede MC (1990). Lithium lengthens circadian period in a diurnal primate, Saimiri sciureus. Biol Psychiatry 28:117-126.
46. Winget CM, DeRoshia CW, Markley CL, Holley DC (1984). A review of human physiological and performance changes associated with desynchronosis of biological rhythms. Aviat Space Environ Med 55:1086-1096.
47. Wirz-Justice A, Benedetti F, Berger M, Lam RW, Martiny K, Terman M, Wu JC (2006). Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med 35:939-944.
48. Yamada N, Shimoda K, Ohi K, Takahashi S, Takahashi K (1988). Free-access to a running wheel shortens the period of free-running rhythm in blinded rats. Physiol Behav 42:87-91.
49. Yang P, Singhal N, Modi G, Swann A, Dafny N (2001). Effects of lithium chlo-ride on induction and expression of methylphenidate sensitization. Eur J Pharmacol 426:65-72.
50. Yin L, Wang J, Klein PS, Lazar MA (2006). Nuclear receptor Rev-erbalpha ¡ a critical lithium-sensitive component of the circadian clock. Science 311:1002-1005.
51. Youdim MB, Arraf Z (2004). Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax. Neuropharmacology 46:1130-1140.